Along this line of reasoning, Huang et al. [75] importantly showed in an MLL-AF9-induced AML mouse model that blocking sEV secretion from ECs, but not perivascular cells, megakaryocytes, or spleen stromal cells, markedly delayed leukaemia progression. The gene discussed is KMT2A; the disease is leukemia.